Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DNS4D6
|
|||
| Drug Name |
KB195
|
|||
| Indication | Urea cycle disorder [ICD-11: 5C50.A; ICD-10: E72.2; ICD-9: 270.6] | Phase 2 | [1] | |
| Company |
Kaleido Biosciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03933410) UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder (UNLOCKED). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.